- Home
- APGE vs JBLU Comparison
APGE vs JBLU Comparison
Compare APGE & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- JBLU
- Stock Information
- Founded
- APGE 2022
- JBLU 1998
- Country
- APGE United States
- JBLU United States
- Employees
- APGE N/A
- JBLU N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- JBLU Air Freight/Delivery Services
- Sector
- APGE Health Care
- JBLU Consumer Discretionary
- Exchange
- APGE Nasdaq
- JBLU Nasdaq
- Market Cap
- APGE 2.1B
- JBLU 1.9B
- IPO Year
- APGE 2023
- JBLU N/A
- Fundamental
- Price
- APGE $41.99
- JBLU $4.08
- Analyst Decision
- APGE Strong Buy
- JBLU Sell
- Analyst Count
- APGE 4
- JBLU 11
- Target Price
- APGE $91.33
- JBLU $4.97
- AVG Volume (30 Days)
- APGE 791.1K
- JBLU 25.4M
- Earning Date
- APGE 08-11-2025
- JBLU 07-29-2025
- Dividend Yield
- APGE N/A
- JBLU N/A
- EPS Growth
- APGE N/A
- JBLU N/A
- EPS
- APGE N/A
- JBLU N/A
- Revenue
- APGE N/A
- JBLU $9,210,000,000.00
- Revenue This Year
- APGE N/A
- JBLU N/A
- Revenue Next Year
- APGE $743.14
- JBLU $7.92
- P/E Ratio
- APGE N/A
- JBLU N/A
- Revenue Growth
- APGE N/A
- JBLU N/A
- 52 Week Low
- APGE $26.20
- JBLU $3.34
- 52 Week High
- APGE $63.50
- JBLU $8.31
- Technical
- Relative Strength Index (RSI)
- APGE 55.77
- JBLU 35.92
- Support Level
- APGE $40.48
- JBLU $4.09
- Resistance Level
- APGE $44.65
- JBLU $4.67
- Average True Range (ATR)
- APGE 2.42
- JBLU 0.23
- MACD
- APGE 0.16
- JBLU -0.12
- Stochastic Oscillator
- APGE 65.90
- JBLU 4.91
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.